Skip to content

The Oncology Institute, Inc. TOI Accumulated Depreciation

Accumulated Depreciation at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
$142.7M+18.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$11.66M+21.8%
McKesson logo
McKessonMCK
Incyte logo
IncyteINCY
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp
FCF margin-5.1%

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by The Oncology Institute, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s accumulated depreciation?
The Oncology Institute, Inc. (TOI) reported accumulated depreciation of $11.83M in Q1 2026.
How has The Oncology Institute, Inc.'s accumulated depreciation changed year-over-year?
The Oncology Institute, Inc.'s accumulated depreciation increased by 48.1% year-over-year, from $7.98M to $11.83M.
What is the long-term trend for The Oncology Institute, Inc.'s accumulated depreciation?
Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s accumulated depreciation has grown at a 53.2% compound annual growth rate (CAGR), from $1.98M to $10.93M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.